Chinese Medicine in Treatment of A Patient with Acute Extensive Anterior Myocardial Infarction Complicated by Shock after Percutaneous Coronary Intervention
|
摘要
<正>Acute myocardial infarction(AMI) is a clinical syndrome of myocardial ischemia and necrosis caused by acute blocking of the coronary artery. When complicated by cardiogenic shock(CS),it has an extremely high mortality.~((1,2)) Early reperfusion therapy
引文
1.De Luca L,Olivari Z,Farina A,Gonzini L,Lucci D,Chiara AD,et al.Temporal trends in the epidemiology,management,and outcome of patients with cardiogenic shock complicating acute coronary syndromes.Eur J Heart Fail 2015;17:1124-1132.
2.Dushen T,Jim N,Ajay J.Management of cardiogenic shock complicating acute coronary syndromes.Heart2013;99:1614-1623.
3.Biswajit K,Igor DG,Sukhdeep SB,Gary M,Pranav L.The percutaneous ventricular assist device in severe refractory cardiogenic shock.J Am Coll Cardiol 2011;57:688-696.
4.Ibanez B,James S,Agewall S,Antunes M,BucciarelliDucci C,Bueno H,et al.2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC).Eur Heart J 2017;1-66.
5.Chinese Society of Cardiology,Editorial Board of Chinese Journal of Cardiology.Guideline of diagnosis and treatment of ST-segment elevation myocardial infarction.Chin JCardiol(Chin)2015;43:380-393.
6.Li J,Li X,Wang Q,Hu S,Wang YF,Frederick AM,et al.ST-segment elevation myocardial infarction in China from2001 to 2011(the China PEACE-Retrospective Acute MyocardialInfarction Study):a retrospective analysis of hospital data.Lancet 2015;385:441-451.
7.Chinese Study Group for Cardiology(and CEI-AMIresearch).Controlled clinical trial of AMI treated with captopril by Chinse study on cardiology:a review of 14,962cases.Chin J Cardioly(Chin)1997;25:245-249.
8.Shang JJ,Shi H,Zhou Q,Gao W,Liu HX.A study of prognosis,outcome,and changing tendency of hospitalized AMI patients in Beijing third-grade A-level traditional Chinese medicine hospitals from 1999 to 2008.Evid Based Complement Alternat Med 2012;2012:837194.
9.Liu HX,Gao W,Zhao D,Shang JJ,Sun JY.Investigation of hospitalization condition of AMI patients in 13 TCMand Western medicine hospitals in Beijing.Chin J Cardiol2010;38:306-310.
10.Tian JF,Li JD,Lei Y,Wang SR,Shang JJ,Liu HX.Investigation of clinical manifestations and treatment of AMIpatients in 26 class A tertiary hospitals in China.Chin JIntegr Tradit West Med(Chin)2012;32:329-332.
11.Wang PL,Zhang L,Wang SL,Yang QN,Gao ZY,Du JP,et al.Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention:A multicenter randomized controlled trial.Chin J Integr Med 2017;23:740-746.
12.Luo J,Xu H,Yang G,Qiu Y,Liu J,Chen K.Oral Chinese proprietary medicine for angina pectoris:an overview of systematic reviews/meta-analyses.Complement Ther Med2014;22:787-800.
13.Luo J,Xu H.Outcome measures of Chinese herbal medicine for coronary heart disease:an overview of systematic reviews.Evid Based Complement Alternat Med 2012;2012:927392.
14.Liu HX.Three methods of managing heart in Beijing TCM.Beijing J Trad Chin Med 2015;34:171-172.
15.Xu XR,Wei ZZ,Xu XG,Wei YX,Gao YH,Huang LJ.Clinical observation of 30 cases of congestive heart-failure treated with heart failure medicament.J Tradit Chin Med1983;11:25-26.
16.Dai M,Wen QX,He JR,Wang ZY,Wang J,Zhang DY.Influence of heart failure medicament on angiotensin-ANFand N-end pro-brain natriuretic peptide of AMI patients.Chin J Integr Trad West Med(Chin)2006;26:888-891.
17.Liu HX,Jin M,Wang ZY,Deng XR,Qin SM,Wang YM,et al.Clinical observation of 113 cases of unstable angina(blood-stasis pattern)treated by Shenyuan Decoction.JTradit Chin Med 1999;4:219-221.
18.Liu HX,Li AY,Xie XR,Wu B,Shang JJ.Influence of prepared Shenyuan Pill on the MDA and SOD level of rat with myocardial ischemia/reperfusion.Chin J Microcircul(Chin)2011;21;80-83.
19.Liu HX.Consensus of TCM experts on the treatment of CI in perioperative period by percutaneous coronary intervention.Chin J Integr Tradit West Med(Chin)2017;37:389-393.
20.Chu FY,Liu W,Liu HX.Influence of qi tonifying and stasis-expelling method on the miR_24 expression and myocardial apoptosis of AMI rats.World Chin Med(Chin)2016;11:392-394.
2.Dushen T,Jim N,Ajay J.Management of cardiogenic shock complicating acute coronary syndromes.Heart2013;99:1614-1623.
3.Biswajit K,Igor DG,Sukhdeep SB,Gary M,Pranav L.The percutaneous ventricular assist device in severe refractory cardiogenic shock.J Am Coll Cardiol 2011;57:688-696.
4.Ibanez B,James S,Agewall S,Antunes M,BucciarelliDucci C,Bueno H,et al.2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC).Eur Heart J 2017;1-66.
5.Chinese Society of Cardiology,Editorial Board of Chinese Journal of Cardiology.Guideline of diagnosis and treatment of ST-segment elevation myocardial infarction.Chin JCardiol(Chin)2015;43:380-393.
6.Li J,Li X,Wang Q,Hu S,Wang YF,Frederick AM,et al.ST-segment elevation myocardial infarction in China from2001 to 2011(the China PEACE-Retrospective Acute MyocardialInfarction Study):a retrospective analysis of hospital data.Lancet 2015;385:441-451.
7.Chinese Study Group for Cardiology(and CEI-AMIresearch).Controlled clinical trial of AMI treated with captopril by Chinse study on cardiology:a review of 14,962cases.Chin J Cardioly(Chin)1997;25:245-249.
8.Shang JJ,Shi H,Zhou Q,Gao W,Liu HX.A study of prognosis,outcome,and changing tendency of hospitalized AMI patients in Beijing third-grade A-level traditional Chinese medicine hospitals from 1999 to 2008.Evid Based Complement Alternat Med 2012;2012:837194.
9.Liu HX,Gao W,Zhao D,Shang JJ,Sun JY.Investigation of hospitalization condition of AMI patients in 13 TCMand Western medicine hospitals in Beijing.Chin J Cardiol2010;38:306-310.
10.Tian JF,Li JD,Lei Y,Wang SR,Shang JJ,Liu HX.Investigation of clinical manifestations and treatment of AMIpatients in 26 class A tertiary hospitals in China.Chin JIntegr Tradit West Med(Chin)2012;32:329-332.
11.Wang PL,Zhang L,Wang SL,Yang QN,Gao ZY,Du JP,et al.Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention:A multicenter randomized controlled trial.Chin J Integr Med 2017;23:740-746.
12.Luo J,Xu H,Yang G,Qiu Y,Liu J,Chen K.Oral Chinese proprietary medicine for angina pectoris:an overview of systematic reviews/meta-analyses.Complement Ther Med2014;22:787-800.
13.Luo J,Xu H.Outcome measures of Chinese herbal medicine for coronary heart disease:an overview of systematic reviews.Evid Based Complement Alternat Med 2012;2012:927392.
14.Liu HX.Three methods of managing heart in Beijing TCM.Beijing J Trad Chin Med 2015;34:171-172.
15.Xu XR,Wei ZZ,Xu XG,Wei YX,Gao YH,Huang LJ.Clinical observation of 30 cases of congestive heart-failure treated with heart failure medicament.J Tradit Chin Med1983;11:25-26.
16.Dai M,Wen QX,He JR,Wang ZY,Wang J,Zhang DY.Influence of heart failure medicament on angiotensin-ANFand N-end pro-brain natriuretic peptide of AMI patients.Chin J Integr Trad West Med(Chin)2006;26:888-891.
17.Liu HX,Jin M,Wang ZY,Deng XR,Qin SM,Wang YM,et al.Clinical observation of 113 cases of unstable angina(blood-stasis pattern)treated by Shenyuan Decoction.JTradit Chin Med 1999;4:219-221.
18.Liu HX,Li AY,Xie XR,Wu B,Shang JJ.Influence of prepared Shenyuan Pill on the MDA and SOD level of rat with myocardial ischemia/reperfusion.Chin J Microcircul(Chin)2011;21;80-83.
19.Liu HX.Consensus of TCM experts on the treatment of CI in perioperative period by percutaneous coronary intervention.Chin J Integr Tradit West Med(Chin)2017;37:389-393.
20.Chu FY,Liu W,Liu HX.Influence of qi tonifying and stasis-expelling method on the miR_24 expression and myocardial apoptosis of AMI rats.World Chin Med(Chin)2016;11:392-394.